Skip to main content

Recursion Pharmaceuticals, Inc.

RXRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001601830

In the last 90 days, Recursion Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 4 sales; 344 institutions reported holding it in 13F filings for Q2 2026, worth $1.33B in total; ARK Invest is the only superinvestor holding it.

13F holders, Q4 2022

Institutional positions in Recursion Pharmaceuticals, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
144
+1 vs. Q3 2022
Shares held
123.7M
+18.9M (+18.0%) vs. Q3 2022
Total value
$954.0M
−$161.7M (−14.5%) vs. Q3 2022
New holders
20
62 more added
Sold out
19
30 more reduced

3 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RXRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2022: 144 institutions
Q1 2021: 1 institutionQ2 2021: 75 institutionsQ3 2021: 84 institutionsQ4 2021: 126 institutionsQ1 2022: 128 institutionsQ2 2022: 133 institutionsQ3 2022: 146 institutionsQ4 2022: 144 institutionsQ1 2023: 159 institutionsQ2 2023: 158 institutionsQ3 2023: 192 institutionsQ4 2023: 199 institutionsQ1 2024: 248 institutionsQ2 2024: 270 institutionsQ3 2024: 268 institutionsQ4 2024: 316 institutionsQ1 2025: 337 institutionsQ2 2025: 333 institutionsQ3 2025: 322 institutionsQ4 2025: 335 institutionsQ1 2026: 335 institutionsQ2 2026: 344 institutions
Value heldQ4 2022: $954.0M
Q1 2021: $1.00KQ2 2021: $1.71BQ3 2021: $1.26BQ4 2021: $1.62BQ1 2022: $680.3MQ2 2022: $861.1MQ3 2022: $1.21BQ4 2022: $954.0MQ1 2023: $841.4MQ2 2023: $952.8MQ3 2023: $1.16BQ4 2023: $2.04BQ1 2024: $2.12BQ2 2024: $1.89BQ3 2024: $1.74BQ4 2024: $2.06BQ1 2025: $1.63BQ2 2025: $1.57BQ3 2025: $1.58BQ4 2025: $1.33BQ1 2026: $1.03BQ2 2026: $1.33B
Institutions holding RXRX and their total value by quarter
QuarterHoldersValue
Q2 2026344$1.33B
Q1 2026335$1.03B
Q4 2025335$1.33B
Q3 2025322$1.58B
Q2 2025333$1.57B
Q1 2025337$1.63B
Q4 2024316$2.06B
Q3 2024268$1.74B
Q2 2024270$1.89B
Q1 2024248$2.12B
Q4 2023199$2.04B
Q3 2023192$1.16B
Q2 2023158$952.8M
Q1 2023159$841.4M
Q4 2022144$954.0M
Q3 2022146$1.21B
Q2 2022133$861.1M
Q1 2022128$680.3M
Q4 2021126$1.62B
Q3 202184$1.26B
Q2 202175$1.71B
Q1 20211$1.00K

Institutions, Q4 2022

Shares, value and share of portfolio for each institution holding Recursion Pharmaceuticals, Inc.; share changes are against Q3 2022.

Institutions holding RXRX in Q4 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Renaissance Technologies LLC193,900$1.50M0.00%+178,700+1,175.7%Added
Mariner, LLC198,725$1.53M0.00%−763−0.4%Reduced
Rhumbline Advisers205,587$1.58M0.00%+863+0.4%Added
Allen Operations LLC217,657$1.68M0.45%00.0%Unchanged
Citigroup Inc232,827$1.80M0.00%+71,267+44.1%Added
First Trust Advisors LP241,147$1.86M0.00%+111,709+86.3%Added
Barclays PLC296,600$2.29M0.00%+184,366+164.3%Added
Morgan Stanley333,171$2.57M0.00%+57,229+20.7%Added
UBS Group AG361,895$2.79M0.00%+343,430+1,859.9%Added
Mitsubishi UFJ Trust & Banking Corp367,390$2.83M0.01%00.0%Unchanged
Alliancebernstein L.P.390,605$3.01M0.00%−2,846,739−87.9%Reduced
Pentwater Capital Management LP400,000$3.08M0.10%+100,000+33.3%Added
Bank of America Corp421,864$3.25M0.00%+222,998+112.1%Added
Nikko Asset Management Americas, Inc.454,522$3.50M0.05%−36,218−7.4%Reduced
Sumitomo Mitsui Trust Holdings, Inc.454,522$3.50M0.00%−36,218−7.4%Reduced
Bank of New York Mellon Corp505,447$3.90M0.00%+1,506+0.3%Added
Goldman Sachs Group Inc583,002$4.49M0.00%+224,936+62.8%Added
Rafferty Asset Management, LLC596,067$4.60M0.04%+423,541+245.5%Added
Millennium Management LLC695,373$5.36M0.01%+455,977+190.5%Added
Citadel Advisors LLC771,150$5.95M0.01%+269,280+53.7%Added
Artal Group S.A.960,204$7.40M0.43%+510,204+113.4%Added
Cercano Management LLC978,051$7.54M0.31%+978,051New
Charles Schwab Investment Management Inc984,681$7.59M0.00%+80,177+8.9%Added
Comprehensive Financial Management LLC1,109,395$8.55M0.28%00.0%Unchanged
Botty Investors LLC1,114,626$8.59M4.07%−1,500−0.1%Reduced
Nuveen Asset Management, LLC1,147,429$8.85M0.00%+300,292+35.4%Added
Northern Trust Corp1,159,703$8.94M0.00%+26,005+2.3%Added
Duquesne Family Office LLCSuperinvestorDuquesne Family Office1,385,950$10.7M0.53%00.0%Unchanged
Harvard Management Co Inc1,509,254$11.6M1.47%00.0%Unchanged
Credit Suisse AG1,575,590$12.1M0.01%+10,235+0.7%Added
MV Management XI, L.L.C.1,971,908$15.2M26.45%00.0%Unchanged
Geode Capital Management, LLC2,609,948$20.1M0.00%+277,865+11.9%Added
Platinum Investment Management Ltd2,710,339$20.9M0.80%+458,368+20.4%Added
ARK Investment Management LLCSuperinvestorARK Invest3,099,490$23.9M0.21%−260,321−7.7%Reduced
Norges Bank4,371,313$33.7M0.01%00.0%Unchanged
FMR LLC4,465,715$34.4M0.00%+214,551+5.0%Added
Laurion Capital Management LP4,825,735$37.2M1.04%+238,461+5.2%Added
Data Collective IV GP, LLC5,941,120$45.8M48.11%00.0%Unchanged
Kinnevik AB (publ)7,653,061$59.0M33.28%+7,653,061New
State Street Corp7,870,958$60.7M0.00%+3,315,199+72.8%Added
MIC Capital Management UK LLP8,451,758$65.2M12.86%00.0%Unchanged
Vanguard Group Inc10,057,363$77.5M0.00%+1,676,377+20.0%Added
BlackRock Inc.10,667,624$82.2M0.00%+900,584+9.2%Added
Baillie Gifford & Co24,820,850$191.4M0.20%+3,226,157+14.9%Added
Massachusetts Financial Services Co0$00.00%−950,594−100.0%Sold out
Graham Capital Management, L.P.0$00.00%−123,702−100.0%Sold out
BNP Paribas Arbitrage, SA0$00.00%−107,034−100.0%Sold out
Advisory Research Inc0$00.00%−96,803−100.0%Sold out
Occudo Quantitative Strategies LP0$00.00%−48,971−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−45,832−100.0%Sold out
Crown Advisors Management, Inc.0$00.00%−30,000−100.0%Sold out
DnB Asset Management AS0$00.00%−26,086−100.0%Sold out
Cna Financial Corp0$00.00%−24,112−100.0%Sold out
US Bancorp0$00.00%−16,200−100.0%Sold out
Ensign Peak Advisors, Inc0$00.00%−15,470−100.0%Sold out
Quantamental Technologies LLC0$00.00%−11,981−100.0%Sold out
Man Group plc0$00.00%−10,671−100.0%Sold out
Macquarie Group Ltd0$00.00%−4,927−100.0%Sold out
O'Dell Group, LLC0$00.00%−1,175−100.0%Sold out
Lindbrook Capital, LLC0$00.00%−122−100.0%Sold out
National Bank of Canada0$00.00%−1,000−100.0%Sold out
Umb Bank N A0$00.00%−4−100.0%Sold out
Community Bank, N.A.0$00.00%−41−100.0%Sold out
Obvious Management Services, L.L.C.––––Not filed
DCVC Opportunity Fund II GP, LLC––––Not filed
Two Sigma Ventures, LP––––Not filed